Molecular Biology Reports · 2011 · 47 citations · 35 references
Life SciencesCell BiologyPharmacologyApoptosisCancer PharmacologyCellular PharmacologyAntioxidant DefenseApoptosis In CancerLipid PeroxidationOxidative Damage To BiomoleculesOxidative StressReactive Oxygen SpeciesAnti-apoptotic AgentsAntioxidant PharmacologyAntioxidant PropertiesCell Death AssaysOxidative Stress - Induced ApoptosisOxidative Stress InjuryOxidative Stress-induced ApoptosisReactive Oxygen Species Generation
Experimental and clinical studies suggest that gliclazide may protect pancreatic β-cells from apoptosis induced by an oxidative stress. However, the precise mechanism(s) of this action are not fully understood and requires further clarification. Therefore, using human normal and cancer cells we examined whether the anti-apoptotic effects of this sulfonylurea is due to its free radical scavenger properties. Hydrogen peroxide (H(2)O(2)) as a model trigger of oxidative stress was used to induce cell death. Our experiments were performed on human normal cell line (human umbilical vein endothelial cell line, HUVEC-c) and human cancer cell lines (human mammary gland cell line, Hs578T; human pancreatic duct epithelioid carcinoma cell line, PANC-1). To assess the effect of gliclazide the cells were pre-treated with the drug. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay was employed to measure the impact of gliclazide on cell viability. Generation of reactive oxygen species, mitochondrial membrane potential (∆Ψ(m)), and intracellular Ca(2+) concentration [Ca(2+)] were monitored. Furthermore, the morphological changes associated with apoptosis were determined using double staining with Hoechst 33258-propidium iodide (PI). Gliclazide protects the tested cells from H(2)O(2)-induced cell death most likely throughout the inhibition of ROS production. Moreover, the drug restored loss of ΔΨ(m) and diminished intracellular [Ca(2+)] evoked by H(2)O(2). Double staining with Hoechst 33258-PI revealed that pre-treatment with gliclazide diminished the number of apoptotic cells. Our findings indicate that gliclazide may protect both normal and cancer human cells against apoptosis induced by H(2)O(2). It appears that the anti-apoptotic effect of the drug is most likely associated with reduction of oxidative stress.
35
Biochemistry and molecular cell biology of diabetic complications
Michael Brownlee · Nature · 2001 · 9K citations
Andrew J. Krentz, Clifford J. Bailey · Drugs · 2005 · 1.1K citations
Pancreatic β‐cell mass in European subjects with type 2 diabetes
J. Rahier, Yves Guiot, Rose‐Marie Goebbels et al. · Diabetes Obesity and Metabolism · 2008 · 741 citations
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.
James Carmichael, William DeGraff, Adi F. Gazdar et al. · PubMed · 1987 · 702 citations
Medicine, Cancer Biology, Oncology +13
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Piero Marchetti, Marco Bugliani, R Lupi et al. · Diabetologia · 2007 · 409 citations · Full text